Is Dianthus Therapeutics, Inc. (DNTH) a Buy, Sell, or Hold?
NASDAQ : DNTH
Dianthus Therapeutics, Inc.
$99.91 USD
-$1.37 (-1.35%)
- Volume
- 745.75K
- Average Volume
- 933.46K
- Market Capitalization
- $4.17B
- P/E Ratio
- -908.27
- Dividend Yield
- 0.00%
- Price Target
- $120.00
- Year High
- $102.37
- Year Low
- $18.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $29.25
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
45
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
60
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$1.32M
DNTH Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DNTH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-07-09 | M-Exempt | 21.77 | 2026-07-13 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-07-09 | M-Exempt | 21.77 | 2026-07-13 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-07-09 | S-Sale | 100.22 | 2026-07-13 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-07-09 | S-Sale | 101.24 | 2026-07-13 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-07-09 | S-Sale | 101.97 | 2026-07-13 |
| Veness Adam M | officer: SVP, General Counsel and Sec. | 2026-06-17 | M-Exempt | 17.88 | 2026-06-18 |
| Veness Adam M | officer: SVP, General Counsel and Sec. | 2026-06-17 | M-Exempt | 17.88 | 2026-06-18 |
| Veness Adam M | officer: SVP, General Counsel and Sec. | 2026-06-17 | S-Sale | 80.34 | 2026-06-18 |
| Veness Adam M | officer: SVP, General Counsel and Sec. | 2026-06-17 | S-Sale | 81.38 | 2026-06-18 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 22.07 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 17.88 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 21.77 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 22.07 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | S-Sale | 89.72 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 21.77 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 17.88 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | S-Sale | 90.72 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 8.44 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | S-Sale | 91.37 | 2026-06-02 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-06-01 | M-Exempt | 8.44 | 2026-06-02 |
| Romano Steven J. | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| Read Simon | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| Lawton Alison Frances | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| McGeorge Anne | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| KANGO SUJAY | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| Violin Jonathan | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| Soteropoulos Paula | director | 2026-05-21 | A-Award | 89.63 | 2026-05-22 |
| Soteropoulos Paula | director | 2026-05-08 | M-Exempt | 8.44 | 2026-05-11 |
| Soteropoulos Paula | director | 2026-05-08 | S-Sale | 85.47 | 2026-05-11 |
| Soteropoulos Paula | director | 2026-05-08 | M-Exempt | 8.44 | 2026-05-11 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-04-09 | M-Exempt | 17.88 | 2026-04-10 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-04-09 | M-Exempt | 17.88 | 2026-04-10 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-04-09 | S-Sale | 89.84 | 2026-04-10 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | M-Exempt | 17.88 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 78.33 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 78.86 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 80.25 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 81.36 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 82.84 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | M-Exempt | 17.88 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | M-Exempt | 8.44 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 83.9 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | M-Exempt | 8.44 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 84.57 | 2026-04-01 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-03-31 | S-Sale | 85.54 | 2026-04-01 |
| Soteropoulos Paula | director | 2026-03-31 | M-Exempt | 8.44 | 2026-04-01 |
| Soteropoulos Paula | director | 2026-03-31 | M-Exempt | 8.44 | 2026-04-01 |
| Soteropoulos Paula | director | 2026-03-31 | S-Sale | 80.11 | 2026-04-01 |
| Soteropoulos Paula | director | 2026-03-24 | M-Exempt | 8.44 | 2026-03-26 |
| Soteropoulos Paula | director | 2026-03-24 | M-Exempt | 8.44 | 2026-03-26 |
| Soteropoulos Paula | director | 2026-03-24 | S-Sale | 78.05 | 2026-03-26 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-16 | M-Exempt | 17.88 | 2026-03-17 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-16 | M-Exempt | 17.88 | 2026-03-17 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-16 | M-Exempt | 6.7 | 2026-03-17 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-16 | M-Exempt | 6.7 | 2026-03-17 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | M-Exempt | 6.7 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | S-Sale | 80.69 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | M-Exempt | 6.7 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | S-Sale | 81.74 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | S-Sale | 82.6 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | S-Sale | 83.38 | 2026-03-13 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-03-12 | S-Sale | 85.53 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 17.88 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 21.77 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 21.77 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 22.07 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 22.07 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | S-Sale | 80.71 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | M-Exempt | 17.88 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | S-Sale | 81.75 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | S-Sale | 82.66 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | S-Sale | 83.38 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-03-12 | S-Sale | 85.53 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 22.07 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 17.88 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 21.77 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 22.07 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 21.77 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 17.88 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 8.44 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | M-Exempt | 8.44 | 2026-03-13 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-03-12 | S-Sale | 81.48 | 2026-03-13 |
| CARR EDWARD | officer: CHIEF ACCOUNTING OFFICER | 2026-02-03 | A-Award | 52.46 | 2026-02-04 |
| Veness Adam M | officer: SVP, General Counsel and Sec. | 2026-02-03 | A-Award | 52.46 | 2026-02-04 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2026-02-03 | A-Award | 52.46 | 2026-02-04 |
| Savitz Ryan | officer: EVP, CFO & CBO | 2026-02-03 | A-Award | 52.46 | 2026-02-04 |
| Garcia Marino | director, officer: CEO AND PRESIDENT | 2026-02-03 | A-Award | 52.46 | 2026-02-04 |
| Savitz Ryan | officer: CFO & CBO | 2025-12-04 | M-Exempt | 8.44 | 2025-12-05 |
| Savitz Ryan | officer: CFO & CBO | 2025-12-04 | M-Exempt | 8.44 | 2025-12-05 |
| Savitz Ryan | officer: CFO & CBO | 2025-12-04 | S-Sale | 45.18 | 2025-12-05 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 22.07 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-13 | M-Exempt | 17.88 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 22.07 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-13 | M-Exempt | 17.88 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-13 | M-Exempt | 8.44 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 21.77 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 17.88 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-13 | S-Sale | 35.8 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 21.77 | 2025-11-14 |
| Randhawa Simrat | officer: EVP, Head of R&D | 2025-11-14 | M-Exempt | 17.88 | 2025-11-14 |